Carvolix SA

€4.90As of Sun 8 Nov 2026, 12:00 UTC
EPA:CVXHealthcare
Country France
PE (Fwd) •••
TSR 5Y CAGR (5.42%)
Div yield —
ROE (91.14%)
Medical Devices
Beta (5Y) 1.17
PE TTM —
TSR TTM 200.61%
Mkt cap €304.9M
ROIC (25.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€6.02
22.87%
(78.81%)
Hold 9|4|8|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.05
0.06
0.06
0.06
0.54%
8.21%
17.79%
15.26%
Revenue€M
25.93
25.61
25.28
24.61
6.02%
4.73%
0.14%
(2.65%)
Peers (US$342.4M)
Cap (US$)
PE
297.9M
37.64x
90.86M
—
Capital
TTM
5Y
10Y
Leveragex
2.437
0.042
0.042
EBIT/Intx
0.913
0.706
0.754
Own earn%
143.86
(6.37)
(8.64)
Sh yield%
43.64
34.74
34.70
Owners
Insiders/Inst%
5.61
55.21
Short interest%
3.56
SBC / revenue%
2.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
3–18
$1 testx
—
Incr. ROIC%
1